K. K. Talwar appointed as the chairman of MCI
The new Board of Governors for the Medical Council of India (MCI) has appointed Cardiologist Dr. K.K. Talwar as the Chairman.
The new Board of Governors for the Medical Council of India (MCI) has appointed Cardiologist Dr. K.K. Talwar as the Chairman.
Imaging on Call, a division of RadNet, Inc., announced that it has enhanced its radiology service offerings in an effort to help hospitals and health care facilities improve the delivery of health care and increase revenues, while helping them expand their practices and be more competitive.
To help finance high-end medical devices for patients, the Medical technology company Medtronic has come up with affordable projects.
Hitachi Data Systems Corporation, a wholly owned subsidiary of Hitachi, Ltd. introduced a new solution for healthcare providers to improve clinical decision making and resulting patient care.
Egton Medical Information Systems (EMIS), the UK’s leading supplier of healthcare software and related services to GPs, has been awarded full roll out approval for the Electronic Prescription Service Release 2 (EPSR2) module of its EMIS Web system.
Boston Scientific Corporation recently announced its launch of the PROMUS
Mount Kellett Capital Management , US private equity group, is investing Rs 410 crore in one of India’s top pharma retailer MedPlus Health Services.
Royal Philips Electronics has acquired Dameca, a global provider of anesthesia machines and accessories for the operating room.
The FCCB holders, funded by QVT, Sun Pharma and Syndicate Bank, hold bonds worth $42 million in a pharmaceutical company Wockhardt Ltd.
To support business growth the promoters of Aegon Religare Life Insurance (ARLI) will introduce about Rs 400 crore in the company in the next financial year to support business growth.
Aurbindo pharma looses 0.91 percent stakes possessed by HSBC Global Investment Funds (Mauritius) Ltd in the open market sales.
Biocon the Biopharma major is planning to set up an academic institution called Biocon Academy next financial year.
The second-largest Indian drug maker, Dr Reddy